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Mycobacterium ulcerans causes Buruli ulcer, an ulcer-
ative skin disease in tropical and subtropical areas. Despite
restricted genetic diversity, mycobacterial interspersed
repetitive unit–variable-number tandem repeat analysis on
M. ulcerans revealed 3 genotypes from different African
countries. It is the first time this typing method succeeded
directly on patient samples. 
B
uruli ulcer (BU), the third most common mycobacter-
ial disease after tuberculosis and leprosy, is a major
health problem in several West and Central African coun-
tries (1). Although endemic in Central America and sub-
tropical climates of Southeast Asia and Australia, countries
in Africa in the past decade have recorded increased inci-
dence rates in some communities exceeding that of tuber-
culosis (2). 
Mode(s) of transmission, natural reservoir(s) and other
key aspects of the epidemiology of BU are not fully under-
stood, a situation partly complicated by an apparent lack of
genetic diversity of Mycobacterium ulcerans, as shown by
several independent genetic markers (3–6). Conventional
and molecular data suggest that M. ulcerans is an environ-
mental pathogen because of the selective association of
BU-endemic foci with wetlands and overflowed river
banks and the detection of M. ulcerans–specific sequences
in water, mud, aquatic insects, and plants (7–9). Specific
reservoirs of the etiologic agent cannot be definitively
assigned; however, we have cultivated M. ulcerans from a
single aquatic insect from Benin (10). 
Extensive molecular typing of M. ulcerans isolates
recovered from patients in many endemic foci has been
undertaken to further the understanding of the epidemiolo-
gy of BU. A set of robust genotyping methods has already
been applied to M. ulcerans: IS2404 restriction fragment
length polymorphism (11), amplified fragment length
polymorphism analysis (AFLP) (12), multilocus sequence
typing (13), variable-number tandem repeat (VNTR) (3),
mycobacterial interspersed repetitive unit (MIRU)–VNTR
(6), IS2426 polymerase chain reaction (PCR) (5), and
IS2404-Mtb2 PCR (4). All methods, except AFLP, result-
ed in geographically related genotypes for China, Japan,
Mexico, Suriname, French Guiana, Malaysia, Papua New
Guinea II and Papua New Guinea III, Australia Victoria,
Australia Queensland, and Africa. Current typing methods
have established a striking geographic and temporal homo-
geneity in African isolates from Angola, Benin,
Democratic Republic of Congo (DRC), Ghana, Côte
d’Ivoire, and Togo (3–6). Even M. ulcerans cultured from
the insect collected in Benin showed an identical African
genotype (6). Recently, however, Hilty et al., using a
VNTR typing method and sequence analysis, described 3
genotypes in Ghana (14). The development of more dis-
criminating typing methods may unravel the source and
mode of transmission of M. ulcerans and other epidemio-
logic aspects of BU.
Improved understanding of the molecular biology of M.
ulcerans will likely help elucidate observed differences in
clinical manifestations. Reported disease recurrence rates
vary from 6% to >20% (15). To what degree this recur-
rence is attributable to exogenous reinfection or dissemi-
nation of the pathogen from previous lesions is unknown.
The relative contribution of variations in pathogen and
host factors to progression and severity of disease likewise
remains obscure.
We report the first evidence of genetic diversity in M.
ulcerans samples from 3 African countries: DRC, Sudan,
and Uganda. Previously, we identified tandem repeat loci,
MIRUs (6), and VNTRs (3) in the genome of M. ulcerans.
A selection of these MIRUs and VNTRs were used in this
study to analyze M. ulcerans extracts from tissue speci-
mens from Benin, Togo, Gabon, Uganda, and Sudan, and
from previous isolates from patients from Cameroon,
DRC, Uganda, and Congo-Brazzaville  (Table 1). Results
were compared with those of a geographically diverse col-
lection (n = 39) that were typed in our previous study (6).
The Study
To investigate the MIRU polymorphism, whole genom-
ic DNA was prepared from bacterial cultures or clinical
specimens. The specimens were tissue fragments from
patients with nonulcerated (plaques and edematous forms)
or ulcerated forms. DNAextraction from pure cultures was
performed by heating the colonies in Tris-EDTA at 95°C
for 10 minutes. Clinical specimens from laboratory-
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reversed Petroff method, and mycobacterial DNA was
extracted from the decontaminated solution as previously
described (6). Smears of the suspensions were stained by
the Ziehl-Neelsen method.
PCR was run as previously described (6). The Agilent
2100 Bioanalyzer system (Agilent Technologies,
Waldbronn, Germany) was used to separate 1 µL of PCR
product electrophoretically. 
Comparison of MIRU-VNTR copy numbers using 4
loci showed 11 different profiles. M. ulcerans isolates from
DRC and Uganda and tissue extracts from patients from
Sudan (Nzara) and Uganda (Nakasongola) showed distinct
profiles (Central Africa: 1222 and East Africa: 4111), dif-
ferent from the originally homogeneous African genotype
(Atlantic Africa: 3113; Table 1). In DRC, 3 different geno-
types exist, corresponding to 3 different provinces: Bas-
Congo, Maniema (Kasongo), and Orientale (Bunia). The
isolate from Orientale was from near the Ugandan border
(Lake Albert). Isolates from Gabon, Congo-Brazzaville,
and Cameroon had the typical African genotype, now des-
ignated the Atlantic African genotype. Identical MIRU-
VNTR profiles were observed by using DNA extracted
from tissues or cultures from patients residing in the same
area. The specificity of the MIRU-VNTR method was test-
ed on 14 different Mycobacterium spp. Only M. marinum,
M. shottsii, and M. liflandii tested positive, but they were
distinguished from M. ulcerans by exhibiting different
profiles (data not shown). Sequencing of the concerned
loci showed the conserved MIRU sequence at locus 1 and
9 in M. ulcerans. Locus 6 (3) and locus 33 contain respec-
tively a 56-bp and a 58-bp tandem repeat (Table 2).
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Although M. ulcerans isolates from Africa are relative-
ly homogeneous, this study demonstrates more hetero-
geneity between strains than previously reported. All
isolates from West Africa (Côte d’Ivoire, Ghana, Togo,
Benin) and Central Africa (Cameroon; Gabon; Congo-
Brazzaville; DRC Bas-Congo; Angola) have the identical
MIRU-VNTR profile, and all originate from regions (i.e.,
Bas-Congo) or countries that border the Atlantic Ocean.
The isolates that come from regions or countries in the
Nile River basin (i.e., Orientale in DRC, Sudan, and
Uganda) or the Congo River basin (i.e., Maniema) have
distinct profiles. 
These results demonstrate for the first time hetero-
geneity among M. ulcerans from different African coun-
tries. The 3 African profiles are the Atlantic African
profile, the Central African Congo River basin profile, and
the East African Nile River basin profile. This is also the
first detection of MIRUs and VNTRs in clinical speci-
mens, even in smear-negative specimens. 
These data show that MIRUs and VNTRs are helpful
tools in genotyping M. ulcerans. Further detailed differen-
tiation of this etiologic agent will lead to an understanding
of the epidemiology of BU. As in tuberculosis, better dis-
criminatory typing methods help assess the efficacy of
antimycobacterial treatment of BU patients by differentiat-
ing reactivation from reinfection. Although M. ulcerans
appears to be quite monomorphic, full sequencing of this
organism will permit detection of genes specific for M.
ulcerans, and more discriminatory VNTR should become
available.
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